These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1306646)

  • 41. [Prenatal blood transfusions for anti-D-erythroblastosis in twin pregnancies (author's transl)].
    Schultze-Mosgau H; Fischer K; Poschmann A; Berle P
    Med Klin; 1974 Jan; 69(3):94-6. PubMed ID: 4206040
    [No Abstract]   [Full Text] [Related]  

  • 42. [A case of severe hemolytic disease of the newborn due to anti-Dia antibody].
    Lee SM; Im SJ; Park SE; Lee EY; Kim HH
    Korean J Lab Med; 2007 Oct; 27(5):373-6. PubMed ID: 18094604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of positive direct antiglobulin test and clinical outcomes in Surinamese newborns from D-negative women.
    Zonneveld R; Lamers M; Schonewille H; Brand A; Kanhai HHH; Zijlmans WCWR
    Transfusion; 2017 Oct; 57(10):2496-2501. PubMed ID: 28681433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Persistent neonatal hyperbilirubinemia resulting from Gilbert's syndrome in association with RhD hemolytic disease].
    Facchini FP; Assis AM
    J Pediatr (Rio J); 2005; 81(5):421-4. PubMed ID: 16247547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Fototherapy of neonatal hyperbilirubinemia. Results of its clinical application (author's transl)].
    Hohenauer L; Haschke F; Gerstl JW
    Klin Padiatr; 1976 Jul; 188(4):314-9. PubMed ID: 988423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neonatal jaundice: physiologic variation or pathologic process.
    Reiser DJ
    Crit Care Nurs Clin North Am; 2004 Jun; 16(2):257-69. PubMed ID: 15145371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous immunoglobulin in hemolytic disease of the newborn: A moving target in time.
    Vardar G; Okan MA; Karadag N; Topcuoglu S; Ozalkaya E; Karatepe HO; Karatekin G
    Niger J Clin Pract; 2022 Aug; 25(8):1262-1268. PubMed ID: 35975373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spectrum of neonatal hyperbilirubinemia: an analysis of 454 cases.
    Singhal PK; Singh M; Paul VK; Deorari AK; Ghorpade MG
    Indian Pediatr; 1992 Mar; 29(3):319-25. PubMed ID: 1612673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prevalence of immunohematologic tests at birth and the incidence of hemolytic disease in the newborn].
    Cianciarullo MA; Ceccon ME; Vaz Fv
    Rev Assoc Med Bras (1992); 2003; 49(1):45-53. PubMed ID: 12724812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Routine administration of intravenous calcium during exchange blood transfusion for treatment of severe neonatal hyperbilirubinaemia: a systematic review of quantitative evidence protocol.
    Orimadegun AE; Akingbola TS
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):134-45. PubMed ID: 26447014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of bilirubin encephalopathy.
    Bertini G; Dani C; Pezzati M; Rubaltelli FF
    Biol Neonate; 2001; 79(3-4):219-23. PubMed ID: 11275655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple dose IVIG treatment in neonatal immune hemolytic jaundice.
    Tanyer G; Siklar Z; Dallar Y; Yildirmak Y; Tiraş U
    J Trop Pediatr; 2001 Feb; 47(1):50-3. PubMed ID: 11245352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes of blood oxygen affinity and capacity and red cell 2,3-diphosphoglycerate evoked by exchange transfusions with ACD preserved blood in newborn infants: their interrelationship and influences on oxygen supply of tissues and erythropoiesis.
    Versmold H; Wenner J; Riegel K
    Z Kinderheilkd; 1972; 113(1):1-18. PubMed ID: 4626818
    [No Abstract]   [Full Text] [Related]  

  • 54. Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.
    Onesimo R; Rizzo D; Ruggiero A; Valentini P
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1059-61. PubMed ID: 20092394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hemolytic disease of neonates due to anti-M: report of one case and review of reports of 21 cases].
    Gao XY; Huang H; Li LD
    Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):648-52. PubMed ID: 20021783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [High dosage immunoglobulin therapy in Rhesus incompatibility].
    Hofstadler G; Hohenauer L
    Klin Padiatr; 1995; 207(3):103-5. PubMed ID: 7623424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperbilirubinemia: current guidelines and emerging therapies.
    Schwartz HP; Haberman BE; Ruddy RM
    Pediatr Emerg Care; 2011 Sep; 27(9):884-9. PubMed ID: 21926893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive value of cord blood bilirubin for hyperbilirubinemia in neonates at risk for maternal-fetal blood group incompatibility and hemolytic disease of the newborn.
    Calkins K; Roy D; Molchan L; Bradley L; Grogan T; Elashoff D; Walker V
    J Neonatal Perinatal Med; 2015; 8(3):243-50. PubMed ID: 26518407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neonatal hyperbilirubinemia.
    Thaler MM
    Semin Hematol; 1972 Apr; 9(2):107-12. PubMed ID: 4623021
    [No Abstract]   [Full Text] [Related]  

  • 60. [Personal experience with the use of light in paraphysiological neonatal hyperbilirubinemia and hemolytic disease of the newborn due to Rh and ABO factors].
    Salvioli GP; Dallacasa P
    Minerva Pediatr; 1972 Feb; 24(3):113-23. PubMed ID: 4622393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.